Our work
RWE4Decisions is a multi-stakeholder initiative led by a diverse Steering Group. It supports open dialogues and produces practical resources to improve how real-world evidence can be generated and used in practice to inform HTA/Payer decisions.
Roundtable Reports
The RWE4Decisions Learning Network organises invitation-only multi-stakeholder roundtables held under Chatham House rules to discuss case studies on RWE in HTA/Payer decision-making, resulting in a detailed report for participants and the public.
March 24, 2025
Report
Roundtable Report: WHO Novel Medicines Platform draft guide principles for Managed Entry Agreement (20 February 2025)
September 12, 2024
Report
Roundtable Report: Post-Launch Evidence Generation (PLEG): Learnings from Italy, Germany, and the French DESCAR-T Registry
November 27, 2022
Press release
10 November Conference: Health Innovation – the European Health Data Space and Real-World Evidence
Published papers
RWE4Decisions builds on experts’ insights and contributes to the broader literature through peer-reviewed journal articles and the publication of actionable recommendations for stakeholder groups.
June 17, 2025
Paper
Actions for Stakeholders to Develop Better Real-World Evidence for HTA/Payer Decision-Making
February 17, 2025
Planning Post-Launch Evidence Generation: Lessons from France, England, and Spain
November 2, 2022
Paper
Can we use existing guidance to support the development of robust real-world evidence for HTA/Payer decision-making?
September 27, 2020
Paper
Real-world Evidence to Support Payer/HTA Decisions about Highly Innovative Technologies in the EU – Actions for stakeholders
Policy engagement
RWE4Decisions actively participates in international meetings and congresses to ensure that the perspectives and learnings from our collaborative multi-stakeholder work contribute to global conversations on the use of real-world evidence by HTA/Payers.
June 17, 2025
Paper
Actions for Stakeholders to Develop Better Real-World Evidence for HTA/Payer Decision-Making
February 17, 2025
Planning Post-Launch Evidence Generation: Lessons from France, England, and Spain
November 2, 2022
Paper
Can we use existing guidance to support the development of robust real-world evidence for HTA/Payer decision-making?
September 27, 2020
Paper
Real-world Evidence to Support Payer/HTA Decisions about Highly Innovative Technologies in the EU – Actions for stakeholders
Event reports
Public Webinars
RWE4Decisions organises several public webinars every year to share insights, foster dialogue, and engage a broader audience in key topics shaping real-world evidence for HTA/Payers. Each webinar is followed by a summary report, available on our website.
November 23, 2023
Report
Real-World Evidence over the Medicine’s Lifecycle to inform HTA/Payer decisions | RWE4Decisions Symposium Report (23 November)
Annual Symposia
Our Symposium every year brings together national and EU policy and decision makers to explore policy issues, share learnings, and collaboratively shape practical solutions, gathered in a comprehensive public report.
November 23, 2023
Report
Real-World Evidence over the Medicine’s Lifecycle to inform HTA/Payer decisions | RWE4Decisions Symposium Report (23 November)
Newsletters
RWE4Decisions actively participates in international meetings and congresses to ensure that the perspectives and learnings from our collaborative multi-stakeholder work contribute to global conversations on the use of real-world evidence by HTA/Payers.
July 30, 2022